Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart D — Serological Reagents](/submissions/MI/subpart-d%E2%80%94serological-reagents) → [21 CFR 866.3340](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3340) → GTB — Antisera, Fluorescent, All Types, Klebsiella Spp.

# GTB · Antisera, Fluorescent, All Types, Klebsiella Spp.

_Microbiology · 21 CFR 866.3340 · Class 1_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTB

## Overview

- **Product Code:** GTB
- **Device Name:** Antisera, Fluorescent, All Types, Klebsiella Spp.
- **Regulation:** [21 CFR 866.3340](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3340)
- **Device Class:** 1
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

Klebsiella spp. serological reagents are devices that consist of antigens and antisera, including antisera conjugated with a fluorescent dye (immunofluorescent reagents), that are used in serological tests to identify Klebsiella spp. from cultured isolates derived from clinical specimens. The identification aids in the diagnosis of diseases caused by bacteria belonging to the genus Klebsiella and provides epidemiological information on these diseases. These organisms can cause serious urinary tract and pulmonary infections, particularly in hospitalized patients.

## Classification Rationale

Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.

## Recent Cleared Devices (0 of 0)

_No cleared devices on record._

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTB](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTB)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com